A Promise in the Treatment of Endometriosis: An Observational Cohort Study on Ovarian Endometrioma Reduction by N-Acetylcysteine

Table 4

Pain evaluation at enrollment and at the end of observation (1–10 VAS scale).

	Controls	Treated	𝑃
Dysmenorrhea
Initial	7.18 ± 2.58 (𝑛=42)	6.43 ± 3.39 (𝑛=38)	ns
Final	7.00 ± 2.79 (𝑛=41)	3.11 ± 3.33 (𝑛=24)	0.001
Dyspareunia
Initial	2.76 ± 3.27 (𝑛=20)	2.83 ± 3.19 (𝑛=23)	ns
Final	2.78 ± 3.31 (𝑛=20)	1.38 ± 2.62 (𝑛=12)	0.027
Chronic pelvic pain
Initial	2.07 ± 3.57 (𝑛=12)	2.47 ± 3.82 (𝑛=15)	ns
Final	1.87 ± 3.42 (𝑛=11)	0.77 ± 2.09 (𝑛=6)	0.015